...
首页> 外文期刊>Folia neuropathologica >Tanshinone IIA alleviates the damage of neurocytes by targeting GLUT1 in ischaemia reperfusion model (in vivo and in vitro experiments)
【24h】

Tanshinone IIA alleviates the damage of neurocytes by targeting GLUT1 in ischaemia reperfusion model (in vivo and in vitro experiments)

机译:丹参酮IIA通过靶向胰岛素再灌注模型(体内和体外实验)来减轻神经细胞的损伤

获取原文
           

摘要

Stroke is partial or complete brain dysfunction combined with acute cerebral circulatory disorders, and it affects millions of individuals around the world each year. A?total of 70-80% of patients experience ischaemic stroke caused by disturbances in cerebral circulation, leading to cerebral ischaemia, neuronal apoptosis, and necrosis. Tanshinone IIA is a?natural compound extracted from Salvia miltiorrhiza and has been proven to assist in recovery from cerebral ischaemia reperfusion injury. GLUT1 is ubiquitously expressed in all types of tissues in the human body and has important physiological functions due to its glucose uptake ability. This experiment was performed to detect the effect of GLUT1 in promoting the therapeutic effect of tanshinone IIA. Here, we found that tanshinone IIA treatment increased the viability of neurons and promoted the recovery of brain function, and that the concentration of glucose in serum and cultured medium was also increased. We noticed that these effects might be mediated by an increased glucose uptake ability. In addition, we further found that the PI3K/mTOR/HER3 signalling pathway played an important role in regulating these effects. Thus, we thought that overexpression of GLUT1 might be an important target in the treatment of cerebral ischaemia-reperfusion.
机译:中风是部分或完全脑功能障碍与急性脑循环疾病联合,每年都会影响全世界数百万个个体。 a?总共70-80%的患者体现脑循环中紊乱引起的缺血性卒中,导致脑缺血,神经元细胞凋亡和坏死。丹参酮IIa是一种来自丹参的天然化合物,已被证明有助于从脑缺血再灌注损伤中恢复。 Glut1在人体中的所有类型组织中普遍地表达,并且由于其葡萄糖摄取能力具有重要的生理功能。进行该实验,检测Glut1对促进丹参酮IIA的治疗作用的影响。在这里,我们发现丹参酮IIA治疗增加神经元的活力并促进脑功能的恢复,并且血清中葡萄糖的浓度也增加了。我们注意到这些效果可能通过增加的葡萄糖摄取能力介导。此外,我们进一步发现,PI3K / MTOR / HER3信号通路在调节这些效果方面发挥着重要作用。因此,我们认为过表达1的过度表达可能是治疗脑缺血再灌注的重要靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号